Intravenous chemotherapy for lung cancer patients vascular care.docVIP

 PAGE \* MERGEFORMAT 8 Intravenous chemotherapy for lung cancer patients vascular care [Abstract] Objective: To reduce lung vascular damage from intravenous chemotherapy. Methods: 326 cases of lung cancer patients before chemotherapy, during and after vascular care. Results: Only 1 case of phlebitis. Conclusion: chemotherapy before, during and after vascular care is the key to the success of chemotherapy, which can effectively protect the vein to prevent vein damage. [Keywords:] lung cancer, venous injury, nursing Intravenous chemotherapy is the main method of treatment of lung cancer, one of a wide range of clinical applications, because chemotherapy drugs are cytotoxic drugs, there is a strong irritant, mild burning sensation caused by local swelling and inflammation or vascular vein occlusion, caused severe cases of drug extravasation local tissue necrosis. Therefore, to do the blood vessels during chemotherapy care is necessary, are as follows. 1 Clinical data Our hospital in September 2007 -2010 in September, 326 cases of lung cancer patients on intravenous care, including: 186 patients with squamous cell carcinoma, adenocarcinoma, 119 cases, 21 cases of small cell carcinoma, 203 cases male, female 123 cases, the maximum age of 78 years old, minimum 19 years old, average course of 6-8 cycles per patient. commonly used chemotherapy drugs cyclophosphamide, mitomycin C, vincristine, doxorubicin, cisplatin, etoposide, 5 - fluorouracil and so on. Results 1 case of phlebitis, no drug leakage occurred. 2 Care 2.1 vein care before chemotherapy 2.1.1 health education: to explain to patients and their families chemotherapy, chemotherapy side effects, and the emergence of the consequences of drug extravasation. Zhu Huanzhe body during chemotherapy drugs to avoid activities, drinking, going to the toilet with the help of others when under the. guiding patient self-monitoring, puncture site pain or unusual occurs, time to tell th